AGARICUS PHALLOIDES (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the AGARICUS PHALLOIDES drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: AGARICUS PHALLOIDES
SUBSTANCE NAME: AMANITA PHALLOIDES WHOLE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


AGARICUS PHALLOIDES HUMAN OTC DRUG Details:

Item DescriptionAGARICUS PHALLOIDES from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6457_f17d47dd-e08a-490a-96e3-a51d5d31dce0
PRODUCT NDC: 60512-6457
APPLICATION NUMBER:

Other AMANITA PHALLOIDES WHOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.AGARICUS PHALLOIDES